To test the effects of soluble DLK1 on glioma growth in vivo, we generated a mouse model for the overexpression of soluble DLK1 together with PDGFB using the RCAS/tv-a system (Figure 7A). The gene discussed is DLK1; the disease is central nervous system cancer.